Latest

19:54
【SG GROUP HLDGS (01657.HK): Appoints Luo Ying, Chen Liangyin and Cao Sheng as Independent Non-Executive Directors; Li Limei Resigns as Executive Director; Zhu Peiqi Resigns as Company Secretary】NewTimeSpace News: On 20 August 2026, SG GROUP HLDGS (01657.HK) appointed Ms. Luo Ying, Mr. Chen Liangyin and Mr. Cao Sheng as independent non-executive directors; Ms. Li Limei resigned as executive director; Mr. Zhu Peiqi resigned as company secretary and was succeeded by Ms. Qian Yingying; the three board committees were realigned accordingly.
Tag： SG GROUP HLDGS01657.HKPersonnel Change
19:52
【DIRECTEL (08337.HK): Proposes Capital Reduction and Subdivision of Unissued Shares, Reducing Par Value from HKD 0.20 to HKD 0.01 per Share】NewTimeSpace News: On 21 August 2026, DIRECTEL (08337.HK) proposed to reduce the par value of each share from HKD 0.20 to HKD 0.01 and subdivide each authorised unissued share into 20 new shares, with an EGM to be held on 11 September 2026 to consider the proposal; the capital reduction will generate a credit of approximately HKD 46.53 million, which the board currently has no intention to apply against accumulated losses.
Tag： DIRECTEL08337.HKCapital Restructuring
19:32
【BCQ(01963.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 3.52 billion, YoY increase of 10.29%】August 20, 2026, BCQ(01963.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 8.43 billion, increased by 12.06% YoY
Tag： BCQ01963.HK
19:32
【YONGHE MEDICAL(02279.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 75.52 million, YoY increase of 170.56%】August 20, 2026, YONGHE MEDICAL(02279.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 980.64 million, increased by 13.82% YoY
Tag： YONGHE MEDICAL02279.HK
19:28
【CR MEDICAL (01515.HK): Appoints Yu Changjiu as Chief Financial Officer, Effective 20 August】NewTimeSpace News: On 20 August 2026, CR MEDICAL (01515.HK) appointed Mr. Yu Changjiu as Chief Financial Officer, effective 20 August 2026. Mr. Yu, aged 46, previously served as General Manager of the Financial Management Centre at China Resources Double-Crane Pharmaceutical and Financial Controller of China Resources Health Group, and holds a Master's degree in Engineering from Beihang University and the title of Senior Accountant.
Tag： CR MEDICAL01515.HKPersonnel Change
19:26
【KAFELAKU COFFEE (01869.HK): Sells Entire Equity of Subsidiary Country Sharp for HKD 8,000, Constituting a Discloseable Transaction】NewTimeSpace News: On 20 August 2026, KAFELAKU COFFEE (01869.HK) announced the disposal of the entire equity of subsidiary Country Sharp to an independent third party for HKD 8,000, constituting a discloseable transaction; the company acknowledged inadvertent oversight in the size test and has implemented compliance remedial measures.
Tag： KAFELAKU COFFEE01869.HKAsset Disposal
19:02
【STELLA HOLDINGS(01836.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 64.04 million, YoY decrease of 18.56%】NewTimeSpace News: August 20, 2026, STELLA HOLDINGS(01836.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 786.67 million, increased by 1.5% YoY.
Tag： STELLA HOLDINGS01836.HKProfit declined
19:02
【CHINA OVS PPT(02669.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 700.58 million, YoY decrease of 9.04%】August 20, 2026, CHINA OVS PPT(02669.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 7.48 billion, increased by 4.52% YoY
Tag： CHINA OVS PPT02669.HK
19:02
【SHUN TAK HOLD(00242.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of HKD 139.43 million, loss widened by 15.76% YoY】NewTimeSpace News: August 20, 2026, SHUN TAK HOLD(00242.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 1.18 billion, decreased by 12.07% YoY.
Tag： SHUN TAK HOLD00242.HKLoss widens
19:02
【XXF(02473.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 17.54 million, YoY decrease of 22%】NewTimeSpace News: August 20, 2026, XXF(02473.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 761.26 million, decreased by 1.03% YoY.
Tag： XXF02473.HKProfit declined
19:02
【FB MINING(02212.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 9.45 million, loss widened by 7.83% YoY】NewTimeSpace News: August 20, 2026, FB MINING(02212.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 64.05 million, increased by 545.29% YoY.
Tag： FB MINING02212.HKLoss widens
19:02
【COMBA(02342.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 55.24 million, YoY decrease of 10.59%】NewTimeSpace News: August 20, 2026, COMBA(02342.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 2.2 billion, increased by 0.02% YoY.
Tag： COMBA02342.HKProfit declined
18:53
【CANSINOBIO (06185.HK): Tetanus Vaccine Receives NMPA New Drug Application Approval, Expanding Adult Vaccine Market】NewTimeSpace News: On 20 August 2026, CANSINOBIO (06185.HK) announced that its adsorbed tetanus vaccine received NMPA new drug application approval; Phase III data showed antibody GMC at 30 days post-immunization superior to the comparator vaccine, and an exclusive commercialization cooperation has been reached with Grand Life Sciences for Greater China.
Tag： CANSINOBIO06185.HKR&D Progress
18:51
【ALLI INTL ED LE (01563.HK): Enters Finance Lease Agreement to Acquire Equipment for RMB 37 Million and Lease Back for Three Years, Total Rental of Approximately RMB 41.075 Million】NewTimeSpace News: On 20 August 2026, ALLI INTL ED LE (01563.HK) entered into a finance lease agreement to acquire production equipment for RMB 37 million and lease it back for three years, with total rental of approximately RMB 41.075 million at an annual rate of 6.58%, constituting a discloseable transaction.
Tag： ALLI INTL ED LE1563.HKFinance Lease
18:37
【HENGRUI PHARMA (01276.HK): SHR-7012 Injection Receives Clinical Trial Approval for Treating Cutaneous Lupus Erythematosus】NewTimeSpace News: On 20 August 2026, HENGRUI PHARMA (01276.HK) disclosed that its subsidiary received the clinical trial approval notice for SHR-7012 injection, indicated for cutaneous lupus erythematosus; no drug targeting the same target has been approved domestically or internationally, with cumulative R&D investment of approximately RMB 25.5 million.
Tag： HENGRUI PHARMA01276.HKR&D Progress
18:35
【BROCKMAN MINING (00159.HK): Polaris Abandons Joint Venture Interest in Ophthalmia Project, Project Fully Held by Brockman East】NewTimeSpace News: On 19 August 2026, BROCKMAN MINING (00159.HK) announced that Polaris abandoned its joint venture interest in the Ophthalmia project effective 1 July 2026, leaving the project wholly owned by wholly-owned subsidiary Brockman East, with a book value of approximately AUD 1.128 million.
Tag： BROCKMAN MINING00159.HKJV Change
18:32
【WG ENV TECH(01845.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 12.27 million, loss widened by 67.17% YoY】NewTimeSpace News: August 20, 2026, WG ENV TECH(01845.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 82.81 million, increased by 2.6% YoY.
Tag： WG ENV TECH01845.HKLoss widens
18:32
【PING AN(02318.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 92.59 billion, YoY increase of 36.06%】August 20, 2026, PING AN(02318.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 615.35 billion, increased by 12.6% YoY
Tag： PING AN02318.HK
18:32
【BABA-W(09988.HK): FY 26/27 Q1 Report - Profit Attributable to Shareholders stood at CNY 10.61 billion, YoY decrease of 73.89%】August 20, 2026, BABA-W(09988.HK) released its Q1 Report for the period ended March 31, 2027, Total Revenue stood at CNY 268.95 billion, increased by 8.6% YoY
Tag： BABA-W09988.HK
18:32
【HENDERSON LAND(00012.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at HKD 4.09 billion, YoY increase of 40.65%】August 20, 2026, HENDERSON LAND(00012.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 17.2 billion, increased by 80.1% YoY
Tag： HENDERSON LAND00012.HK
Previous1..5051 525354..491     491 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments